Ideal candidates for GLP-1 therapy include: Men with a BMI of 30 or higher, regardless of other health conditions Men with a BMI of 27+ who also have at least one weight-related condition such as hypertension, hypertension, dyslipidemia, insulin resistance, or sleep apnea ( 8 ) Men whove had difficulty maintaining long-term weight loss despite reasonable diet and exercise efforts GLP-1s may not be appropriate for men who: Have a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 ( 9 ) Have a history of pancreatitis or certain gallbladder issues Are currently dealing with severe gastrointestinal conditions Are allergic to any component of the medication Before beginning any GLP-1 program, its important to undergo bloodwork and a comprehensive health assessment to ensure youre a good candidate
The literature around this topic is growing, yet most publications on GLP-1s for SUD have been limited to animals (Bruns et al., 2024
[7] As a result, MB is contraindicated in patients with known G6PD deficiency, and screening for this enzyme deficiency is recommended when considering MB therapy, especially in populations where G6PD deficiency is more prevalent
Here are brief clinical reconstitution guidelines for tirzepatide, semaglutide, or any other therapeutics
Because so much immune activity is rooted in the gut, the same process that influences digestion can influence energy and clarity, which is why chronic fatigue sometimes lifts as the inflammatory load settles
And what might make them hike interest rates faster than we think
